ACCESSION: MSBNK-SMB_Measured-HSA014R0243001
RECORD_TITLE: Uridine; LC-ESI-QFT; MS2; NEGATIVE; Generated from DDA dataset; Annotation confidence level 3
DATE: 2025.09.27
AUTHORS: Ryosuke Hayasaka, Akiyoshi Hirayama (Keio Univ.), and Fumio Matsuda (Univ. Osaka)
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
PROJECT: Shin-MassBank project supported by JST
COMMENT: Annotation confidence level 3. The metabolite structure was manually curated by the Shin-MassBank project. This metabolite is found from more than five datasets with confidence level 3
COMMENT: The metabolite structure was automatically characterized by the Shin-MassBank project (see COMMENT: CONFIDENCE). One of the possible structures is shown. The record should be used with caution.
COMMENT: This is an averaged mass spectra data created by averaging 35 product ion spectra among 27 DDA data files in the dataset described below.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: PRECURSOR_IN_MS1 mz 243.062399; int 51.627; delta(ppm) 0.403033
COMMENT: PROPOSED_MF SevenGoldenRules 0.619; C9H12N2O6; [M-H]1; delta(ppm) 0.618676; Ranking 1;
COMMENT: PROPOSED_MF MS-FINDER 3.769; C9H12N2O6; [M-H]-; delta(ppm) 0.622484; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Sirius 34.864; C9H12N2O6; [M-H]-; delta(ppm) 0.622484; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H12N2O6; [M-H]-; delta(ppm) 0.622484; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Sirius 55.617; C9H12N2O6; [M-H]-; delta(ppm) 0.622484; Ranking 1;
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H12N2O6; [M-H]-; delta(ppm) 0.622484; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 15.000; DRTQHJPVMGBUCF-XVFCMESISA-N; C9H12N2O6; Uridine - 40.0 eV; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; DRTQHJPVMGBUCF-UHFFFAOYSA-N; C9H12N2O6; uridine CollisionEnergy:205060; Ranking 2;
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.834; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O; Ranking 1;
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.749; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; Uridine; Ranking 1;
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.773; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; Uridine; Ranking 5;
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.866; DRTQHJPVMGBUCF-XVFCMESISA-N; [M-H]-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.449; DRTQHJPVMGBUCF; [M-H]-; b-Uridine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.644; DRTQHJPVMGBUCF; [M-H]-; b-Uridine; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -12.729; DRTQHJPVMGBUCF; [M-H]-; Uridin; Ranking 1;
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.890; DRTQHJPVMGBUCF; [M-H]-; Uridin; Ranking 1;
COMMENT: CONFIDENCE Tentative candidate (Level 3); Proposed by SIRIUS6_Confidence (FDR < 0.1); Similarity by SIMILARITY:GNPS (Dot product > 0.7, 22 spectra); Supported by CFM-ID:MsfinderDB (Ranking 1), MS-FINDER:MsfinderDB (Ranking 1), MetFrag:MsfinderDB (Ranking 5), MetFrag:PubchemLite (Ranking 1); Biological context by HMDB (HMDB0000296)
CH$NAME: Uridine
CH$NAME: Uridin
CH$NAME: 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H12N2O6
CH$EXACT_MASS: 244.069536
CH$SMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
CH$IUPAC: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)
CH$LINK: HMDB HMDB0000296
CH$LINK: INCHIKEY DRTQHJPVMGBUCF-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:1177
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 1.50; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.950
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 243.062411
MS$DATA_PROCESSING: COMMENT Product ions not positively corelated with the precursor ion were removed (rank order correlation, alpha = 0.01).
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0ik9-2930000000-2bc2987e07ce1b3f1f62
PK$ANNOTATION: m/z int mzPAF cor n
  66.034969 145 f{C4H4N1}/0.71ppm,p-C5H7N1O6 0.9146 35
  82.029942 299 f{C4H4N1O1}/1.28ppm,p-C5H7N1O5 0.9140 35
  110.024767 999 f{C5H4N1O2}/0.14ppm,p-C4H7N1O4 0.9513 35
  111.020185 66 f{C4H3N2O2}/1.66ppm,p-C5H8O4 0.8081 35
  122.024761 85 f{C6H4N1O2}/0.07ppm,p-C3H7N1O4 0.8936 35
  140.035392 101 f{C6H6N1O3}/0.54ppm,p-C3H5N1O3 0.8946 34
  152.035440 175 f{C7H6N1O3}/0.81ppm,p-C2H5N1O3 0.9179 35
  153.030543 69 f{C6H5N2O3}/-0.15ppm,p-C3H6O3 0.8372 32
  200.056481 337 f{C8H10N1O5}/0.18ppm,p-C1H1N1O1 0.9392 35
  243.062579 239 f{C9H11N2O6}/1.31ppm,p 1.0000 35
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  66.034969 145.00 145
  82.029942 299.00 299
  110.024767 999.00 999
  111.020185 66.00 66
  122.024761 85.00 85
  140.035392 101.00 101
  152.035440 175.00 175
  153.030543 69.00 69
  200.056481 337.00 337
  243.062579 239.00 239
//
